ICON Expands Asia Pacific Footprint With New Focus On Southeast Asian Countries
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Driven by increasing interest for drug development programs in Southeast Asia, Ireland-based ICON is expanding its Asia Pacific footprint in the Philippines